Nexstim Plc's Financial Information in 2015


Helsinki, 12 December 2014 at 5:00 pm

Nexstim Plc will publish the following financial information in 2015:

  * The 2014 Financial Statements Bulletin and Half-Yearly Report July-December
    2014 (H2) on Thursday, February 26, 2015
  * Half-Yearly Report January-June 2015 (H1) on Thursday, August 20, 2015

Nexstim  Annual Report  2014 will be  published on  company web pages on Monday,
March 9, 2015.

The Annual General Meeting is tentatively scheduled to be held on Tuesday, March
31, 2015 at 9:00 a.m.


Board of Directors

For further information please visit or contact:

 Nexstim                                                040 8615046
 Janne Huhtala, Chief Executive Officer

 UB Capital Oy (Certified Adviser)                     09 2538 0225

 Consilium Strategic Communications             +44 (0)20 3709 5700
 Mary-Jane Elliott            
 Amber Bielecka
 Ivar Milligan
 Laura Thornton

About Nexstim

Nexstim,  formed in 2000 and  based in Finland,  is a medical technology company
aiming  to improve rehabilitation for stroke patients. Nexstim has pioneered its
technology  in  brain  diagnostics  with  the  Navigated Brain Stimulation (NBS)
system  as the first  and only FDA-cleared  and CE-marked navigated Transcranial
Magnetic  Stimulation (nTMS)  device for  pre-surgical mapping  of the motor and
speech  cortices.  Based  on  the  same  technology  platform,  the  company has
developed  a device for stroke therapy called Navigated Brain Therapy (NBT®). In
H1 2014, Nexstim initiated a two-year pivotal Phase III study at 12 sites in the
US  aiming to demonstrate the  effectiveness of NBT® and  gain FDA clearance for
commercialisation  in post-acute stroke therapy in  the US. Nexstim's shares are
listed  on Nasdaq First  North Finland and  Nasdaq First North  Sweden. For more
information please visit